CD4 and HIV infectious disease: Thus, CD64+ LILRA2+ CD32a+ CD4+ T-cell populations that increase in proportion during primary HIV infection and cART treatment may be more prone to activation through the engagement of CD32a, CD64, or LILRA2 activating receptors.